Massimo Ghiani
Ospedale di Circolo di Busto Arsizio(IT)
Publications by Year
Research Areas
Head and Neck Cancer Studies, Lung Cancer Treatments and Mutations, Nausea and vomiting management, Cancer Immunotherapy and Biomarkers, Head and Neck Surgical Oncology
Most-Cited Works
- Cytokine activity in cancer-related anorexia/cachexia: role of megestrol acetate and medroxyprogesterone acetate.(1998)
- → Cytokine Involvement in Cancer Anorexia/ Cachexia: Role of Megestrol Acetate and Medroxyprogesterone Acetate on Cytokine Downregulation and Improvement of Clinical Symptoms(1998)107 cited
- → Clinical and pathological factors influencing survival in a large cohort of triple-negative breast cancer patients(2018)93 cited
- → Megestrol acetate in neoplastic anorexia/cachexia: clinical evaluation and comparison with cytokine levels in patients with head and neck carcinoma treated with neoadjuvant chemotherapy(1995)75 cited
- → Comparison of granisetron, ondansetron, and tropisetron in the prophylaxis of acute nausea and vomiting induced by cisplatin for the treatment of head and neck cancer: a randomized controlled trial(1996)53 cited
- → Efficacy of the combination of cisplatin with either gemcitabine and vinorelbine or gemcitabine and paclitaxel in the treatment of locally advanced or metastatic non-small-cell lung cancer: a phase III randomised trial of the Southern Italy Cooperative Oncology Group (SICOG 0101)(2006)47 cited
- → Tumor-associated lympho-monocytes from neoplastic effusions are immunologically defective in comparison with patient autologous PBMCs but are capable of releasing high amounts of various cytokines(1997)43 cited
- → Histologic subtyping affecting outcome of triple negative breast cancer: a large Sardinian population-based analysis(2020)35 cited
- → Is pain part of a systemic syndrome in head and neck cancer?(2019)24 cited
- → Neo-adjuvant chemo-(immuno-)therapy of advanced squamous-cell head and neck carcinoma: a multicenter, phase III, randomized study comparing cisplatin + 5-fluorouracil (5-FU) with cisplatin + 5-FU + recombinant interleukin 2(1998)22 cited